Abstract
Morphine tolerance and dependence were investigated in scopolamine-treated rats. The results showed that scopolamine treatment (up to 2 mg/kg) did not affect basal line or morphine-induced latency in the tail-flick test but significantly increased the escape latency in the Morris water-maze task. Co-administration of scopolamine could considerably attenuate development of morphine tolerance and naloxone-precipitated withdrawal syndrome. Pretreatment of scopolamine for 7 days prior to morphine administration also significantly reduced the tolerance and withdrawal symptoms. Scopolamine treatment was further shown to attenuate morphine-induced conditioned place preference, an indicator of morphine psychological dependence. The present study demonstrated the attenuation of morphine tolerance and dependence in scopolamine-treated animals, probably related to scopolamine-produced learning and memory impairment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
